2
(Adds details throughout) Sept 21 (Reuters) – Life sciences Iambic Therapeutics filed for an initial public offering in the US on Monday. The San Diego, California-based company plans to sell new
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)